Pulmonx Corp — Director's Dealing 2021

Sep 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-09-01

Reporting Person: French Glendon E. III (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-01	Common Stock	S	1421	$40.09	Disposed	1180370	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23571	Indirect

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2: The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.